Reckitt

Activities: Body Care Skin Care Pharmaceutical

Trending Articles

  1. New material captures coronavirus particles to boost face mask efficiency Researchers at the University of Liverpool have looked to significantly boost face mask efficiency by developing a new material that captures coronavirus particles
  2. Engineering firm Dornan makes Royal Institution of Chartered Surveyors history Dornan has been the first MEP contractor in Ireland to receive the RISE Corporate Support Scheme Badge from the Royal Institution of Chartered Surveyors
  3. Time is money: renting a mobile cleanroom saves both Every executive has their company’s ”burn rate” in mind and in order to stay alive they must reach critical milestones that are set by the investor. Davis Verheyen from...
  4. MSA Safety opens Morocco PPE manufacturing facility MSA Safety has marked the grand opening of a new Manufacturing Operations centre in Chelalate, Morocco
  5. Legionella testing: Modern alternatives to the ‘gold standard’ test The development of significantly faster, more sensitive testing protocols provide more options for detection Legionella than the complex plate culture test, but these also have...

Upcoming event

Interphex

16-18 April 2024 | Conference and Exhibition | New York, US See all

Related Content

Analysis

Reckitt recalls select batches of infant formula powder

Reckitt voluntarily recalled select batches of Nutramigen Hypoallergenic Infant Formula Powder due to possible health risk
Design & Build

M+W Group starts building RB’s new Centre for Scientific Excellence in UK

Groundwork has already begun on the R&D Centre in Dansom Lane, Hull, that will provide a GMP development facility and pilot plant
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Microbial risks in cosmetics & toiletries

Those tasked with controlling bioburden in the personal care industry are facing many new challenges. The latest microbial detection equipment will flag up anything and everything in a product, which then has to be identified and risk assessed, sometimes leading to unnecessary product recalls. As well as identifying the species, it is necessary to understand the infectivity or pathogenicity of the specific genomed-bacteria in question.
Subscribe now